Supplementary Figure S2. Knockdown of GRHL2 results in the up-regulation of vimentin and N-cadherin.
(a) mRNA expression fold change (y-axis) in GRHL2, E-cadherin (CDH1), Ncadherin (CDH2) and vimentin (VIM), as measured by RT-qPCR in shLuc control (white bars), shGRHL2 #10 (black bars) and shGRHL2 #12 (grey bars) cells of PEO1, OVCA420 and OVCA429. Unpaired t-tests were performed on the 2 -∆Ct values for each gene, ** p < 0.01; *** p < 0.001. (b) Immunofluorescence stainings of vimentin in control (shLuc, shNon) and GRHL2-knockdown (shGRHL2 #10, #12) cells of PEO1 and OVCA429. Scale = 50 µm. (c) Immunofluorescence stainings (upper) of N-cadherin in control (shLuc, shNon) and GRHL2-knockdown (shGRHL2 #10, #12) OVCA429 cells. White arrow indicates junctional N-cadherin observed in shGRHL2 #10 OVCA429 cells. Scale = 50 µm. Western blots (lower) of N-cadherin and β-actin in the stable cell lines of OVCA429. Full-length blots are presented in Supplementary Figure S10 . (d) Immunofluorescence stainings of pan-cytokeratin in the stable cell lines of PEO1, OVCA420 and OVCA429. Scale = 50 µm. (e) A simplified representation of the stepwise changes that occur in the phenotype (PEO1, OVCA429) and molecular subtype (OVCA429) of GRHL2-knockdown cells involving EMT markers E-cadherin, N-cadherin, cytokeratin and vimentin. and F-actin (phalloidin) staining in control and GRHL2-knockdown PEO1 (upper panels), OVCA420 (middle panels), and OVCA429 (lower panels) cells. Scale = 50 µm. (a) GRHL2 ChIP-qPCR in PEO1 and OVCA429 at intron 2 of CDH1 and the promoter regions of CLDN4, RAB25 and ZEB1. Signals of IgG control and ChIP samples were normalized to input DNA and presented as % input with SEM from three independent experiments. % input of GRHL2 ChIP samples were compared with IgG control using unpaired t-tests. * p < 0.05; ** p < 0.01; *** p < 0.001. Two primer pairs were tested for ZEB1 promoter and no enrichment was detected by primer pair 1. (b) DNA sequences (enhancer/promoter) of different genes flanked by the primer pairs used in ChIP-qPCR. The GRHL2 binding motifs are labelled in red. Numbers refer to the distance (in base pairs) relative to the transcription start site (TSS) of each gene. For ZEB1, the distance relative to the TSS of both NM_001128128 and NM_030751 gene transcripts are indicated. Bar charts showing the normalized mRNA expression (2 -∆Ct ) (y-axis) of five EMT transcriptional drivers (ZEB1, ZEB2, SNAI1, SNAI2 and TWIST1) measured by RTqPCR in control (white bars), shGRHL2 #10 (black bars), and shGRHL2 #12 (grey bars) cells of PEO1, OVCA420 and OVCA429. Unpaired t-tests were performed for statistical significance. * p < 0.05; ** p < 0.01; *** p < 0.001. 
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